Datapharm

What Datapharm does

Datapharm is a UK-based, private medicines information technology company founded in 1977 and headquartered in Leatherhead. It operates emc (electronic medicines compendium), the UK's authorized, ABPI-aligned reference for Summaries of Product Characteristics (SmPCs) and Patient Information Leaflets (PILs), covering more than 10,000 medicines supplied by 320+ pharmaceutical companies and consumed by 26 million users in 2025 (including 8.7 million PIL downloads). The platform is trusted by 97% of UK healthcare professionals and is the first-choice reference for 81% of HCPs. Datapharm is also a Certified B Corporation.

The company's product portfolio is built on a FHIR-structured data layer embedded with NHS dm+d identifiers, integrating with NHS BSA, NICE, and the Specials Pharmacy Service. Core offerings include emc (publishing and HCP-facing reference), MLR (Medical, Legal, and Regulatory review workflow), SRD (Structured Regulatory Document, piloted via MILE and recently held in-house after the ODL acquisition), emc icomply (compliance solution), and Change Broadcast (regulatory change notifications). The business sells to pharma companies through modular SaaS pricing — legacy per-medicine publishing fees around £8,000 — with multi-product enterprise contracts likely materially larger and increasingly layered with AI-driven MLR review through the Siguru partnership.

Datapharm monetizes a vertically-specialized, regulated content and workflow stack across the UK pharma industry, with international expansion underway via the Rote Liste (Germany) and VIDAL (France) partnerships for its SRD service. The combination of regulatory role, structured data, and embedded workflow tools positions it as a critical infrastructure provider for UK medicines information.

Name

Datapharm

Legal name

Datapharm Limited

Website

https://www.datapharm.com/

Company type

Private

Founded year

1977

Operating status

Operating

Headcount range

11–50 employees

Short description

Datapharm operates the UK's emc medicines information platform, providing FHIR-structured SmPCs, PILs, and MLR/SRD workflow tools to 320+ pharma companies and serving 26 million UK healthcare users.

Ownership category

akta.pro rank

Product category

Pharmaceutical regulatory information software

NAICS

Software Publishers (51321)

SIC

Services-Computer Programming, Data Processing, Etc. (7370)

akta.pro primary industry

Small-Molecule CMC Documentation & Regulatory Support (DMF/CMC) (HLAGAHAM)

akta.pro secondary industries

Safety Database Operations & Hosting (Argus/ARISg/Oracle) (HLAGALAB), Clinical & Translational Informatics (Clinical Data Integration/Real-World Data for R&D) (HLAGAJAF)

Keywords

• Pharmaceutical regulatory software
• Medicines information platform
• Medical compliance solutions
• Healthcare data interoperability
• Electronic medicines compendium

Headquarters

HQ city

Leatherhead

HQ country

United Kingdom

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Software

Cost components

Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure

Revenue model

1. SaaS subscription solutions for Pharma: Annual subscription-based software solutions including emc regulatory publishing, emc compliance, emc market access, and emc market intelligence. Pharma companies pay for platform access, publishing services, and compliance tools.
2. Data licensing and API access: Organizations license emc and dm+d content for integration into their own systems. RESTful API access for automated data extraction and updates.
3. Accessibility services: Conversion of PILs to ePILs, braille, large print, audio and video formats for regulatory compliance.

Go-to-market motion2 records

Distribution channels8 records

Marketing channels7 records

Core offering

Datapharm operates emc (electronic medicines compendium), the UK's most comprehensive online medicines information database listing over 10,000 medicines with SmPCs, PILs, ePILs, RMMs and DHPCs, serving as a trusted source for healthcare professionals, patients and over 320 pharmaceutical companies. Around this core platform, the company sells an integrated suite of SaaS solutions covering regulatory publishing (emc regulatory), ABPI code compliance for sales and marketing teams (emc compliance), NHS dm+d submissions and supply chain product information management (emc market access), HCP engagement analytics (emc market intelligence), and digital Scientific Response Document search (SRDs). Revenue is generated primarily from annual enterprise subscriptions paid by pharmaceutical companies, supplemented by data and API licensing and professional accessibility services.

Product overview

Datapharm operates as a medicines information technology company offering a platform-plus-modules architecture centered on emc (electronic medicines compendium), the UK's trusted medicines database. The platform provides a suite of integrated solutions: emc regulatory for publishing medicines safety documents (SmPCs, PILs, ePILs); emc compliance for sales and marketing teams featuring emc icomply (mobile/desktop app) and emc pi portal; emc market access including the dm+d submission tool and supply chain PIM platform; emc market intelligence for analytics and audience insights; and Scientific Response Documents (SRDs) for HCP self-service access to pharma medical information. Supporting tools include emc publisher for content management, emc analytics for engagement reporting, and change broadcast for SmPC communications. The solutions are available as individual modules or integrated suite, serving over 320 Pharma companies in the UK.

Differentiator

Problem solved

Functional benefit

Brands

• emc (electronic medicines compendium): The UK's trusted medicines information database listing over 10,000 medicines, serving healthcare professionals and patients.
• emc regulatory
• emc compliance
• emc market access
• emc market intelligence
• Scientific Response Documents (SRDs)
• emc icomply

Products and services

• emc (electronic medicines compendium) The UK's trusted medicines information database listing over 10,000 medicines with up-to-date, accessible SmPCs, PILs, ePILs, RMMs and DHPCs for healthcare professionals and patients; trusted by over 320 pharmaceutical companies and millions of users annually.
• emc regulatory Publishing solution for regulatory, medical information and pharmacovigilance teams to publish medicines safety information on emc in SmPCs, PILs, ePILs, RMMs and DHPCs, with accessibility conversion to braille, large print, audio and video.
• emc compliance Compliance solution enabling Pharma Sales & Marketing and Regulatory teams to remain ABPI-compliant by linking all digital assets to the latest prescribing information, with audit-ready reporting for monitoring adherence.
• emc market access Market access solution including the emc med data dm+d submission tool for NHS dictionary of medicines and devices, and the emc supply chain platform for managing and distributing product information with up to 70 attributes per pack.
• emc market intelligence Market intelligence solution enabling Pharma Sales & Marketing teams to understand HCP engagement with product information, track medicine information changes and access analytics and reporting on product pages and audience demographics.
• Scientific Response Documents (SRDs) Digital HCP engagement solution enabling Medical Information teams to make Scientific Response Documents searchable on emc, allowing healthcare professionals to self-serve answers to medical questions beyond SmPC and PIL 24/7 through a trusted independent channel; now available in UK, Germany and France.

Quantifiable outcome

• MLR review cycles reduced from 40 days to 7 days through Siguru AI partnership
• +3 more outcomes

Named customers23 records

Segments4 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

Yes

API docs

API detail

Core technology

AI maturity

App detail

Integration10 records

AI capability6 records

Feature8 records

Partnerships

Six partnerships are on record, tiered core, regional and minor.

• Siguru AIcoreTechnology or Integration · 18 March 2026Strategic partnership integrating structured medicine safety information from emc into Siguru's AI-driven Medical, Legal, and Regulatory (MLR) review platform for pharmaceutical promotional materials. Aims to reduce MLR review cycles from 40 days to 7 days and increase single review rounds by 75%.
• Original Digital Limited (ODL)coreStrategic or Co-development Partner · 22 July 2024Acquisition of Original Digital Limited, a healthcare technology provider, to enhance the emc medicines information platform and expand SRD search technology. Original Digital previously collaborated on the SRD pilot with MILE.
• MILE (Medical Information Leaders in Europe)coreStrategic or Co-development Partner · 15 February 2023Cross-industry collaboration to pilot Scientific Response Documents (SRD) on emc. Four major pharmaceutical companies participated in pilot running February to December 2023. SRD service has now gone into full production enabling HCPs to self-serve medicines information 24/7.
• Rote ListeregionalGTM or Marketing PartnerPartnership with Rote Liste, a leading provider of medicines information in Germany, to make SRD search accessible to healthcare professionals in Germany.
• VIDALregionalGTM or Marketing PartnerPartnership with VIDAL, a leading provider of medicines information in France, to make SRD search accessible to healthcare professionals in France.
• Gravitate-HealthminorStrategic or Co-development PartnerCollaboration with Gravitate-Health and HL7 as part of Vulcan Accelerator programme to develop worldwide data standard for structured medicines information using FHIR.

Scale indicators10 records

Recent moves7 records

Expansion highlights7 records

Direct peers

• Wolters Kluwer Clinical Solutions (Medi-Span, Lexicomp): Wolters Kluwer's clinical drug information brands (Medi-Span, Lexicomp) provide authoritative medicines information databases integrated into EHRs and clinical decision support systems globally, competing directly with emc for HCP trust and enterprise pharma licensing deals.
• First Databank (FDB): First Databank provides drug knowledge bases and medication decision support integrated into major EHR systems in the US, UK, and beyond; its drug data licensing model closely parallels Datapharm's API/data licensing business with EHRs and NHS systems.
• IBM Micromedex: IBM Micromedex is an enterprise clinical decision support solution providing evidence-based drug information to hospitals and HCPs globally; it overlaps with Datapharm's medicines information publishing and clinical decision support integration use cases.
• Pharmaceutical Press (BNF, Martindale): Pharmaceutical Press publishes the British National Formulary (BNF), Martindale, and Stockley's Drug Interactions — the UK's other authoritative medicines references for HCPs; it serves as Datapharm's most direct content-level competitor in the UK clinical medicines information category.
• Drugs.com: Drugs.com is a major consumer-facing medicines information resource aggregating data from sources including the FDA label and other regulatory documents; it competes with emc for HCP/patient search traffic and medicines information trust.

Regional players

• MIMS (Monthly Index of Medical Specialties): MIMS is a leading medicines information reference serving primarily Asia-Pacific and select other markets; it competes in the same medicines compendium category as emc but serves different geographies, making it a regional rather than direct competitor.

Broad incumbents

• Elsevier Clinical Solutions (ClinicalKey): Elsevier's ClinicalKey and related clinical reference platforms provide drug information alongside broader clinical content to HCPs and institutions; it overlaps with Datapharm's emc but as part of a much wider portfolio rather than a focused medicines compendium.
• Veeva Systems: Veeva Systems provides pharma cloud solutions including regulatory, medical, and commercial applications (e.g., Veeva Vault, PromoMats) that intersect with Datapharm's compliance and regulatory publishing offerings; it operates at significantly larger scale across the pharma value chain.
• Cerner / Oracle Health: Oracle Health (formerly Cerner) provides EHR and clinical decision support systems globally that consume medicines information data from suppliers like Datapharm; it is both a channel partner and a broader incumbent that bundles competing drug information features into its platforms.

Emerging players

• DrugBank: DrugBank provides a structured drug data platform used by researchers, developers, and increasingly HCPs; it overlaps with Datapharm's API-licensed medicines data business but focuses more on research/developer use cases than regulated HCP publishing.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

• Xx.com/eMCdatapharm
• YouTubeyoutube.com/channel/UCn_UiBOJqD3cz3jkYcT8J0g
• Facebookfacebook.com/DatapharmLimited
• LinkedInlinkedin.com/company/datapharm-limited
• Instagraminstagram.com/datapharm_limited

Compliance4 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Datapharm